Sandro Hoffmann is a scientist specializing in mAb discovery at Numab Therapeutics AG since July 2025. Previously, Sandro worked at BioNTech SE as a scientist focused on infectious disease vaccines from October 2023 to June 2025. Sandro's academic journey includes a PhD in B cell immunology and experience as a master student at DKFZ German Cancer Research Center. Earlier roles include a research internship at DKFZ, a working student position at Merck KGaA, and an internship that culminated in a bachelor's thesis at N-zyme Biotec GmbH. Sandro holds a Master of Science degree in biomolecular engineering from Technische Universität Darmstadt and a Bachelor of Science degree in biotechnology from Darmstadt University of Applied Sciences.
This person is not in the org chart
This person is not in any teams
This person is not in any offices